Y Intercept (Hong Kong) LTD Evolus, Inc. Transaction History
Y Intercept (Hong Kong) LTD
- $3.75 Billion
- Q2 2025
A detailed history of Y Intercept (Hong Kong) LTD transactions in Evolus, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 259,487 shares of EOLS stock, worth $2.31 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
259,487
Previous 37,361
594.54%
Holding current value
$2.31 Million
Previous $449,000
432.07%
% of portfolio
0.06%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding EOLS
# of Institutions
187Shares Held
52.7MCall Options Held
142KPut Options Held
58.4K-
Tang Capital Management LLC San Diego, CA5MShares$44.5 Million3.9% of portfolio
-
Perceptive Advisors LLC New York, NY4.13MShares$36.8 Million2.08% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$35.7 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.65MShares$32.5 Million1.98% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.23MShares$28.8 Million0.0% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $500M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...